SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-19-010764
Filing Date
2019-08-14
Accepted
2019-08-14 16:25:44
Documents
67
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q zsan-20190630x10q.htm 10-Q 1270959
2 EXHIBIT 10.1 exhibit101.htm EX-10.1 274621
3 EXHIBIT 31.1 zsan-20190630xexhibit_311.htm EX-31.1 9825
4 EXHIBIT 31.2 zsan-20190630xexhibit_312.htm EX-31.2 10411
5 EXHIBIT 32.1 zsan-20190630xexhibit_321.htm EX-32.1 13231
  Complete submission text file 0001628280-19-010764.txt   7079714

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT zsan-20190630.xml EX-101.INS 1516395
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zsan-20190630.xsd EX-101.SCH 51478
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT zsan-20190630_cal.xml EX-101.CAL 89337
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zsan-20190630_def.xml EX-101.DEF 204943
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zsan-20190630_lab.xml EX-101.LAB 668841
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zsan-20190630_pre.xml EX-101.PRE 386011
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36570 | Film No.: 191026799
SIC: 2834 Pharmaceutical Preparations